A double-blind phase I trial comparing fast-acting insulin with insulin aspart and regular insulin in healthy volunteers.

Trial Profile

A double-blind phase I trial comparing fast-acting insulin with insulin aspart and regular insulin in healthy volunteers.

Completed
Phase of Trial: Phase I

Latest Information Update: 10 Aug 2011

At a glance

  • Drugs Insulin; Insulin aspart
  • Indications Type 1 diabetes mellitus
  • Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics; Therapeutic Use
  • Most Recent Events

    • 10 Aug 2011 New trial record
    • 15 Jun 2011 Results will be presented at the 2nd Annual Protein Formulation Development Forum, the 71st Scientific Sessions of the American Diabetes Association and the 38th Annual Meeting of the Controlled Release Society, according to an Adocia media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top